On the methodology of drug trials in migraine with aura
- 27 April 2010
- journal article
- Published by SAGE Publications in Cephalalgia
- Vol. 30 (9) , 1041-1048
Abstract
Introduction: Specific problems occur in clinical treatment trials for migraine with aura that differ from those encountered in treatment trials for migraine without aura. Discussion: Based on our experience with four such trials, we point to a number of possible solutions and outline areas for future inquiry. We make recommendations about subject selection; the choice, definition and assessment of outcome measures; optimal treatments in relation to aura and headache; and we provide samples of study report forms used to record occurrence of aura and headache in this population.Keywords
This publication has 47 references indexed in Scilit:
- Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover studyThe Lancet Neurology, 2009
- Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in AdultsCephalalgia, 2008
- No effect of eletriptan administration during the aura phase of migraineEuropean Journal of Neurology, 2004
- Guidelines for Controlled Trials of Drugs in Migraine: Second EditionCephalalgia, 2000
- Guidelines for Controlled Trials of Drugs in Cluster Headache: First Edition: International Headache Society Committee on Clinical Trials in Cluster HeadacheCephalalgia, 1995
- Guidelines for Trials of Drug Treatments in Tension-Type HeadacheCephalalgia, 1995
- Subcutaneous sumatriptan during the migraine auraNeurology, 1994
- Guidelines for Controlled Trials of Drugs in Migraine. First EditionCephalalgia, 1991
- Classic Migraine: Effective Prophylaxis with MetoprololCephalalgia, 1987
- Clinical Trial of Nimodipine for Single Attacks of Classic MigraineCephalalgia, 1985